✦ LIBER ✦

434 Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/− Trastuzumab Followed by Docetaxel in Locally Advanced Breast Cancer (LABC)

✍ Scribed by M.K. Tuxen; S. Cold; U.B. Tange; S.B. Soendergaard; D.L. Nielsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective phase II study of neoadjuvan

✍ Taher A. Al-Tweigeri; Dahish S. Ajarim; Adher A. Alsayed; Mohamed M. Rahal; Moha 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 272 KB

Prospective phase II study of: neo-adjuv

✍ T. Al-Tweigeri; Rahal; D. Ajarim; A. Al-Sayed; A. Tulba; O. Al-Malik; M. Al-Shab 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Phase II Study of Neoadjuvant Docetaxel/

✍ Steven A. Limentani; Adam M. Brufsky; John K. Erban; Mohammed Jahanzeb; Deborah 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 490 KB

A phase I/II trial of non-pegylated lipo

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Phase II study of neoadjuvant treatment

✍ Gumersindo Pérez Manga; Parham Khosravi Shahi; Miguel Méndez Ureña; Rosa Quiben 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 214 KB

433 PUBLICATION A phase II study of neoa

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB